| DEA / Controlled Substances Act | Federal: all controlled substance handling | Receipt completeness, perpetual inventory, biennial count timing, record retention windows, custody chain integrity |
|---|
| DSCSA | Federal: prescription drug supply chain | Lot-level traceability, transaction history completeness, trading partner verification, suspect product handling |
|---|
| HIPAA | All PHI-handling entities | Role-based access enforcement, minimum necessary access, audit log completeness, disclosure tracking |
|---|
| USP Chapter 797 | Sterile compounding operations | Environmental monitoring cadence, beyond-use dating, batch release documentation, personnel qualification currency |
|---|
| State Board of Pharmacy | State-by-state requirements | Inventory cadence, technician supervision ratios, policy and procedure compliance, licensure currency |
|---|
| FDA 21 CFR Part 820 / QMSR | Medical device manufacturers | Design history file completeness, CAPA closure integrity, document control, supplier qualification |
|---|
| FDA 21 CFR Part 803 (MDR) | Medical device adverse event reporting | Reportability determination, 30-day and 5-day window tracking, event classification consistency |
|---|
| SOC 2 | SaaS handling sensitive client data | Security, availability, processing integrity and confidentiality control evidence |
|---|